Medical management of patients with brain tumors

被引:68
作者
Wen, PY
Marks, PW
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Neuro Oncol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Neurol, Div Neuro Oncol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Hematol, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA
关键词
D O I
10.1097/00001622-200205000-00008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The most common medical problems in brain tumor patients involve the management of seizures, peritumoral edema, medication side effects, and venous thromboembolism. Despite the importance of these issues, there are very few studies specifically addressing them. Nonetheless, there has been some progress in recent years. There is increasing evidence that brain tumor patients who have not had a seizure do not benefit from prophylactic antiepileptic medications. Patients taking corticosteroids are at greater risk of Pneumocystis carinii pneumonia and may benefit from prophylactic therapy. There is also growing evidence suggesting that anticoagulation may be more effective than inferior vena cava filtration devices for treating venous thromboembolism in brain tumor patients and that the risk of hemorrhage with anticoagulation is relatively small. (C) 2002 Lippincott Williams Wilkins, Inc.
引用
收藏
页码:299 / 307
页数:9
相关论文
共 129 条
[1]   Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery [J].
Agnelli, G ;
Piovella, F ;
Buoncristiani, P ;
Severi, P ;
Pini, M ;
D'Angelo, A ;
Beltrametti, C ;
Damiani, M ;
Andrioli, GC ;
Pugliese, R ;
Iorio, A ;
Brambilla, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (02) :80-85
[2]   Clinical uses gf low-molecular-weight heparins [J].
Aguilar, D ;
Goldhaber, SZ .
CHEST, 1999, 115 (05) :1418-1423
[3]   THE RISK AND EFFICACY OF ANTICOAGULANT-THERAPY IN THE TREATMENT OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH PRIMARY MALIGNANT BRAIN-TUMORS [J].
ALTSCHULER, E ;
MOOSA, H ;
SELKER, RG ;
VERTOSICK, FT .
NEUROSURGERY, 1990, 27 (01) :74-77
[4]   INCREASED TENIPOSIDE CLEARANCE WITH CONCOMITANT ANTICONVULSANT THERAPY [J].
BAKER, DK ;
RELLING, MV ;
PUI, CH ;
CHRISTENSEN, ML ;
EVANS, WE ;
RODMAN, JH .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (02) :311-315
[5]  
Batchelor T, 1996, NEUROSURG CLIN N AM, V7, P435
[6]   Steroid myopathy in cancer patients [J].
Batchelor, TT ;
Taylor, LP ;
Thaler, HT ;
Posner, JB ;
DeAngelis, LM .
NEUROLOGY, 1997, 48 (05) :1234-1238
[7]   The pathogenesis of tumour associated epilepsy [J].
Beaumont, A ;
Whittle, IR .
ACTA NEUROCHIRURGICA, 2000, 142 (01) :1-15
[8]  
Bilsky Mark, 1993, P309
[9]   POSTOPERATIVE PROPHYLACTIC ANTICONVULSANT THERAPY IN CEREBRAL GLIOMAS [J].
BOARINI, DJ ;
BECK, DW ;
VANGILDER, JC .
NEUROSURGERY, 1985, 16 (03) :290-292
[10]   Incidence and risk of thromboembolism during treatment of high-grade gliomas: a prospective study [J].
Brandes, AA ;
Scelzi, E ;
Salmistraro, G ;
Ermani, M ;
Carollo, C ;
Berti, F ;
Zampieri, P ;
Baiocchi, C ;
Fiorentino, MV .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (10) :1592-1596